GlaxoSmithKline to Pay $460M to Resolve Avandia Lawsuits

Bloomberg -- GlaxoSmithKline Plc agreed to pay about $460 million to resolve a majority of lawsuits alleging the company’s Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.